Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 5965

1.

Benefits of Nut Consumption on Insulin Resistance and Cardiovascular Risk Factors: Multiple Potential Mechanisms of Actions.

Kim Y, Keogh JB, Clifton PM.

Nutrients. 2017 Nov 22;9(11). pii: E1271. doi: 10.3390/nu9111271. Review.

2.

SIRT1 Regulates Cognitive Performance and Ability of Learning and Memory in Diabetic and Nondiabetic Models.

Cao Y, Yan Z, Zhou T, Wang G.

J Diabetes Res. 2017;2017:7121827. doi: 10.1155/2017/7121827. Epub 2017 Oct 15. Review.

3.

Effects of pioglitazone therapy on blood parameters, weight and BMI: a meta-analysis.

Filipova E, Uzunova K, Kalinov K, Vekov T.

Diabetol Metab Syndr. 2017 Nov 14;9:90. doi: 10.1186/s13098-017-0290-5. eCollection 2017. Review.

4.

Parasite-Derived Proteins for the Treatment of Allergies and Autoimmune Diseases.

Wu Z, Wang L, Tang Y, Sun X.

Front Microbiol. 2017 Nov 7;8:2164. doi: 10.3389/fmicb.2017.02164. eCollection 2017. Review.

5.

Placental Nutrient Transport in Gestational Diabetic Pregnancies.

Castillo-Castrejon M, Powell TL.

Front Endocrinol (Lausanne). 2017 Nov 7;8:306. doi: 10.3389/fendo.2017.00306. eCollection 2017. Review.

6.

Orthostatic Intolerance in Older Persons: Etiology and Countermeasures.

Goswami N, Blaber AP, Hinghofer-Szalkay H, Montani JP.

Front Physiol. 2017 Nov 9;8:803. doi: 10.3389/fphys.2017.00803. eCollection 2017. Review.

7.

Insulin Resistance and Alzheimer's Disease: Bioenergetic Linkages.

Neth BJ, Craft S.

Front Aging Neurosci. 2017 Oct 31;9:345. doi: 10.3389/fnagi.2017.00345. eCollection 2017. Review.

8.

Mechanisms of Osteoarthritic Pain. Studies in Humans and Experimental Models.

Eitner A, Hofmann GO, Schaible HG.

Front Mol Neurosci. 2017 Nov 3;10:349. doi: 10.3389/fnmol.2017.00349. eCollection 2017. Review.

9.

Leptin action in normal and pathological pregnancies.

Pérez-Pérez A, Toro A, Vilariño-García T, Maymó J, Guadix P, Dueñas JL, Fernández-Sánchez M, Varone C, Sánchez-Margalet V.

J Cell Mol Med. 2017 Nov 21. doi: 10.1111/jcmm.13369. [Epub ahead of print] Review.

10.

Recent advances in understanding/managing type 2 diabetes mellitus.

Aschner P.

F1000Res. 2017 Oct 31;6. pii: F1000 Faculty Rev-1922. doi: 10.12688/f1000research.11192.1. eCollection 2017. Review.

11.

Empagliflozin -- Benefit Assessment According to §35a Social Code Book V [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2016 May 30.

12.

Edoxaban -- Benefit Assessment According to §35a Social Code Book V [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Oct 28.

13.

Urinary Proteome Analysis for Detection of Diabetic Nephropathy in Patients with Diabetes Mellitus and Arterial Hypertension [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Sep 17.

14.

Insulin Degludec / Liraglutide (Addendum to Commission A15-15) [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Sep 24.

15.

Empagliflozin / Metformin -- Benefit Assessment According to §35a Social Code Book V [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2016 May 30.

16.

Insulin Degludec (Addendum to Commission A15-10) [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Aug 7.

17.

Dulaglutide (Addendum to Commission A15-07) [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Jun 25.

18.

Insulin Degludec / Liraglutide: Benefit Assessment According to §35a Social Code Book V [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Jul 30.

19.

Insulin Degludec / Liraglutide (New Therapeutic Indication) -- Benefit Assessment According to §35a Social Code Book V [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Nov 11.

20.

Exploratory Examination of the Need for Revision of the DMP "Coronary Heart Disease" [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2016 Feb 18.

Supplemental Content

Loading ...
Support Center